Attendee Breakdown

Join leaders developing oligonucleotide therapies for CNS disorders to discuss delivery, targeting, and clinical translation, and connect with peers across biotech, pharma, and academia working to move the field forward.

Explore the full breakdown and see who's in the room.

Companies in Attendance

Aarhus University · AbbVie · Alnylam Pharmaceuticals · Aperture Therapeutics · Atalanta Therapeutics · Avidity Biosciences · Beacon · Biogen · BioMarin Pharmaceutical · Bonito Biosciences · CAMP4 Therapeutics · Creyon Bio · D2B3 · Dyne Therapeutics · Eli Lilly & Co. · Entrada Therapeutics · ExRNA Therapeutics · Fuku Biotech · GATEHOUSE BIO · GondolaBio · Grünenthal · Leal Therapeutics · Neurvati Neurosciences · Nissan Chemical America Corporation · NS Pharma · Ophidion · Opprtna Therapeutics · ProteinQure · Quiver Bioscience · QurAlis Corp. · Regeneron Pharmaceuticals · Riboway Therapeutics · Roche · Sanofi · Stoke Therapeutics · Switch Therapeutics · Trace Neuroscience · University of Massachusetts Medical School · University of Pennsylvania · Valaya Bio

Job Titles Represented

Associate Director, BD & Ops · Chief Executive Officer · Chief Executive Officer & Founder · Chief Innovation & Scientific Officer Engineering & Technical; C-Suite · Chief Managing Director · Chief Medical Officer Medical & Health; C-Suite · Chief Scientific Officer Engineering & Technical · Chief Scientific Officer Medical & Health; Engineering & Technical; C-Suite · Chief Technology Officer · Chief Technology Officer Technology · Director - Drug Metabolism & Pharmacokinetics Operations; Engineering & Technical · Director Neuroscience Research · Director, Neurobiology Biology · Director, Oligonucleotide Chemistry Genetic Medicines · Director, Translational Medicine Medical & Health · Founder & Chief Executive Officer · Founder & Chief Executive Officer C-Suite · Founder & Chief Executive Officer Executive · Head Of Gene & Protein Modulation Lab, Discovery Biology Lab Head · Head of Innovation Research Partnering · Head, Drug Development · Manager Open Innovation Office · Postdoctoral fellow · Principal Research Scientist Engineering & Technical · Principal Scientist Engineering & Technical · Principal Scientist Principal Scientist · Principle Associate Engineering & Technical · Professor Biomedicine · Research Assistant Prefossor Neuroscience · Researcher · Scientific Director Biologics Drug Discovery · Scientist Biologics · Scientist Engineering & Technical · Senior Director New Modalities · Senior Director NGTz · Senior Scientist · Senior Scientist I Engineering & Technical · Senior Vice President Engineering & Technical · Senior Vice President · SVP Business Development · Vice President & Head of Neuroscience C-Suite · Vice President & Head of Oligonucleotide Therapeutics · Vice President

67550 - attendee breakdown

Explore the Full Event Guide

Discover three days of highly technical, data‑driven discussions tackling the most pressing challenges in CNS drug development.

What you’ll find inside:

  • Full expert speaker faculty
  • Sessions featuring brand‑new data
  • Unmissable workshop sessions
  • Insight into dedicated networking opportunities
  • A breakdown of expected audience

Your definitive guide - share with your team to assess relevance and mobilize internal interest.

6th Oligonucleotides for CNS Summit 2026 Brochure